Skip to main content
Home

Main navigation

  • About Ipnet
    • What is Ipnet ?
    • Statutes & bylaws
    • Membership application
    • Expert Clinical Center application
    • Ipnet Executive Board
    • General Assemblies
    • Ipnet Working Groups
    • Porphyria centres
    • Patient organizations
    • Corporate members
    • Honorary members
  • Patients
    • Introduction to porphyria
    • GPAC information statement
    • Acute porphyria
    • Drugs and acute hepatic porphyrias
    • Acute porphyria - diagnosis - FAQ
    • Porphyria Cutanea Tarda (PCT)
    • Erythropoietic Protoporphyrias (EPP & XLP)
    • Congenital erythropoietic porphyria (CEP)
    • Skin Protection in Cutaneous Porphyria
    • Patient organizations
    • Porphyria centres
  • Professionals
    • The porphyrias
    • Laboratory diagnosis
    • Investigating the family
    • Treatment of the acute attack
    • Drugs and acute hepatic porphyrias
    • Help for Clinicians
    • Porphyria Cutanea Tarda (PCT)
    • Erythropoietic protoporphyria (EPP & XLEPP)
    • Webinars
    • Porphyria centres
  • News
  • Research
  • Contact

Moderna Inc

Company name
Moderna Inc
Company address
200 Technology Sq
Cambridge, MA 02139, USA
Contact email
info@moderemovernatx.com
Website
https://www.modernatx.com/
Tel
1 617-7146500
Contact
Chief Scientific Officer Rare Diseases
Name
Paolo Martini
Email
Paolo.martremoveini@modernatx.com
Tel
1 617-2095961
Porphyria Related Activities
Messenger RNA therapy encoding hPBGD testing in animal models of Acute Intermittent Porphyria
Home | Disclaimer | GDPR